Loading clinical trials...
Loading clinical trials...
Safety and Efficacy of Venetoclax, Cytarabine and Metformin (VenCM) for Relapsed-Refractory and Induction-Ineligible Acute Myeloid Leukemia: Multicenter, Phase 2, Clinical Trial
Conditions
Interventions
Venetoclax
Cytarabine Injection
+1 more
Locations
5
Brazil
Hospital Ophir Loyola
Belém, Brazil
Hospital de Clínicas da UFPR
Curitiba, Brazil
Hospital Universitario Polydoro Ernani de Sao Thiago
Florianópolis, Brazil
Hospital Amaral Carvalho
Jaú, Brazil
Hospital Municipal Sao Jose
Joinville, Brazil
Start Date
December 1, 2023
Primary Completion Date
July 1, 2026
Completion Date
July 1, 2028
Last Updated
August 5, 2024
NCT06285890
NCT06220162
NCT04065399
NCT06484062
NCT06994676
NCT04628026
Lead Sponsor
Hospital Municipal São José
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions